Nick Harvey

Nick Harvey has been serving as the Chief Financial Officer since September 2020, bringing over two decades of expertise in building and financing life science and technology businesses. His career includes a previous role as the Chief Financial Officer at Centrexion Therapeutics, a privately held biotechnology company. He significantly contributed to Radius Health as the Chief Financial Officer for over ten years, during which he played a pivotal role in the company’s successful initial public offering in 2014 and its transition from a research and development entity to a commercial stage company. Before his tenure at Radius Health, Harvey was a Managing Director at Shiprock Capital, a venture capital firm focused on the development of early and expansion-stage companies. He holds an MBA from Harvard Business School and has earned both a law degree and an undergraduate degree in Economics from the Australian National University.